1. Intravenous administration of poorly soluble new drug entities in early drug discivery: The potential impact of formulation on pharmacokinetic parameters;Bittner;Curr Opin Drug Disc Dev,2002
2. Physicochemical properties of Solutol HS 15 and its solubisates;Ruchatz;BASF ExAct,1998
3. Solutol HS 15, nontoxic polyoxyethylene esters of 12-hydroxystearic acid, reverses multidrug resistance;Coon;Cancer Res,1991
4. Diverse multidrug-resistance-modification agents inhibit cytolytic activity of natural killer cells;Chong;Cancer Immunol Immunother,1993
5. Comparison of Solutol HS 15, Cremophor EL and novel ethoxylated fatty acid surfactants as multidrug resistance modification agents;Buckingham;Int J Cancer,1995